155 related articles for article (PubMed ID: 27140191)
1. A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers.
Rades D; Kaesmann L; Janssen S; Schild SE
Lung; 2016 Aug; 194(4):625-9. PubMed ID: 27140191
[TBL] [Abstract][Full Text] [Related]
2. External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.
Käsmann L; Abdo R; Eze C; Dantes M; Taugner J; Gennen K; Roengvoraphoj O; Rades D; Belka C; Manapov F
Lung; 2020 Feb; 198(1):201-206. PubMed ID: 31897594
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer.
Käsmann L; Janssen S; Schild SE; Rades D
Anticancer Res; 2016 Mar; 36(3):1089-91. PubMed ID: 26977003
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of effectiveness and safety of different treatment modes for limited-stage small cell lung].
Shen J; Wang LH; Zhang FQ; Wang MZ; Li Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):343-7. PubMed ID: 23827076
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.
Manapov F; Klöcking S; Niyazi M; Belka C; Hildebrandt G; Fietkau R; Klautke G
Strahlenther Onkol; 2012 Jan; 188(1):29-34. PubMed ID: 22189436
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.
Käsmann L; Bolm L; Schild SE; Janssen S; Rades D
Lung; 2017 Apr; 195(2):217-224. PubMed ID: 28154994
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer.
Käsmann L; Bolm L; Janssen S; Rades D
Anticancer Res; 2017 Mar; 37(3):1535-1537. PubMed ID: 28314330
[TBL] [Abstract][Full Text] [Related]
10. Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer.
Kaesmann L; Janssen S; Schild SE; Rades D
Lung; 2016 Apr; 194(2):295-8. PubMed ID: 26883133
[TBL] [Abstract][Full Text] [Related]
11. A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer.
Rades D; Käsmann L; Schild SE; Janssen S
Clin Lung Cancer; 2016 Nov; 17(6):558-562. PubMed ID: 27341791
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
[TBL] [Abstract][Full Text] [Related]
13. Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response.
Fujii M; Hotta K; Takigawa N; Hisamoto A; Ichihara E; Tabata M; Tanimoto M; Kiura K
Lung Cancer; 2012 Oct; 78(1):107-11. PubMed ID: 22858447
[TBL] [Abstract][Full Text] [Related]
14. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
[TBL] [Abstract][Full Text] [Related]
16. The first survival score for patients with brain metastases from small cell lung cancer (SCLC).
Rades D; Dziggel L; Segedin B; Oblak I; Nagy V; Marita A; Schild SE
Clin Neurol Neurosurg; 2013 Oct; 115(10):2029-32. PubMed ID: 23871680
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of downstaging in patients with limited-disease small-cell lung cancer.
Go SI; Keam B; Kim TM; Lee SH; Kim DW; Kim HJ; Wu HG; Chung DH; Heo DS
Clin Lung Cancer; 2014 Mar; 15(2):e1-6. PubMed ID: 24356090
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of surgery combined with chemoradiotherapy in treating limited-stage small cell lung cancer and prognosis analysis.
Gu W; Zhong XLXLY
J BUON; 2021; 26(3):812-818. PubMed ID: 34268940
[TBL] [Abstract][Full Text] [Related]
20. Role of surgical resection for patients with limited disease-small cell lung cancer.
Takenaka T; Takenoyama M; Inamasu E; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Lung Cancer; 2015 Apr; 88(1):52-6. PubMed ID: 25662387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
